MDCT angiography to evaluate the therapeutic effect of PTVE for esophageal varices

Table 2 Single- and multiple-factor analysis of relative rebleeding rate factors after modified percutaneous transhepatic variceal embolization

Variable	Univariate	Multivariate
	P value	Hazard ratio (95%CI)	P value
Gender (male vs female)	0.591	-	NS
Age, yr (≥ 53 vs < 53)	0.966	-	NS
Child-Pugh classification C vs (A + B)	0.031	1.730 (1.1394-2.6279)	0.010
Cause: Hepatitis B + hepatitis C vs alcoholic liver disease vs other	0.557	-	NS
Obliteration type	0.000	3.279 (2.132-5.042)	0.000
Variceal grade, severe	0.909	-	NS
Portal hypertensive gastropathy (yes vs no)	0.036	2.525 (0.898-7.097)	0.075
Encephalopathy (yes vs no)	0.065	-	NS
Ascites (yes vs no)	0.024	0.702 (0.252-1.958)	0.217
Laboratory findings
Leukocytes (× 109/L) (≥ 4.6 vs < 4.6)	0.726	-	NS
Hemoglobin (g/L) (< 83.7 vs≥ 83.7)	0.103	-	NS
Platelets (× 109/L) (< 94.9 vs≥ 94.9)	0.437	-	NS
ALT (U/L) (< 88.2 vs≥ 88.2)	0.649	-	NS
Albumin (g/L) (< 32.1 vs≥ 32.1)	0.138	-	NS
Bilirubin (μmol/L) (< 29.3 vs≥ 29.3)	0.240	-	NS
Prothrombin time(s) (≥ 16.4 vs < 16.4)	0.176	-	NS
Creatinine (μmol/L) (≥ 72.7 vs < 72.7)	0.385	-	NS

ALT: Alanine transaminase; NS: Not significant.